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Objective: Health-related quality of life (HRQoL) following
transplantation is gaining importance as an endpoint, but little is
known about the role of normal personality traits as a determinant
of HRQoL in this patient group. We investigated whether Type D
personality (tendency to experience increased negative emotions
paired with the nonexpression of these emotions) was associated
with impaired HRQoL in heart transplant recipients. Methods:
Data were collected from all surviving heart transplant recipients
z21 years of age (n=186) with a mean (S.D.) of 7 (5) years
following transplantation. Patients completed the Short-Form
Health Survey 36 (SF-36) and the Type D Scale (DS14). Clinical
data were obtained from the medical records. Results: Of the
186 patients, 18% had a Type D personality. Type D patients had
significantly worse scores on the Physical Component scale (PCS)0022-3999/06/$ – see front matter D 2006 Elsevier Inc. All rights reserved.
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E-mail address: s.s.pedersen@uvt.nl (S.S. Pedersen).(P=.04) and the Mental Component scale (MCS) (Pb.001) of the
SF-36 and all the SF-36 subdomains (all Pb.01) compared with
non-Type D patients, except for Bodily Pain. Type D personality
remained an independent determinant of impaired PCS [odds ratio
(OR), 3.62; 95% confidence interval (CI), 1.25–10.45] and MCS
(OR, 6.13; 95% CI, 2.23–16.83) and six of the eight subscales of
the SF-36, adjusting for demographic and clinical characteristics.
Conclusions: Type D personality was associated with more than a
three- to six-fold increased risk of impaired HRQoL in heart
transplant recipients, showing that the Type D personality construct
also has value in heart transplant recipients. The adoption of a
personality approach may lead to improved risk stratification in
research and clinical practice in this patient group.
D 2006 Elsevier Inc. All rights reserved.Keywords: Health-related quality of life; Heart transplantation; Type D personalityIntroduction
Since the survival rate for heart transplant recipients has
improved to 60% at 7 years, health-related quality of life
(HRQoL) following transplantation has become an impor-
tant endpoint [1]. The study of HRQoL in this patient group
is not only important because it may lead to improved
patient-centered care [2], HRQoL has also been associated
with increased risk of mortality in patients with cardiovas-cular disease (CVD) [3–5]. In order to identify subgroups of
recipients at risk for impaired HRQoL and to enhance
secondary prevention in these high-risk patients, knowledge
of the determinants of HRQoL is important. Knowledge of
these determinants may also close the gap between research
and clinical practice [2].
In this context, a personality approach may provide a
particularly valuable framework, as personality has much
explanatory power of individual differences in psycholog-
ical distress, HRQoL, and adverse health outcomes [6,7].
From a screening point of view, a personality approach is
also advantageous, since personality traits exert stable
effects on behaviour, whereas mood states (e.g., anxiety
and depression) are transient and fluctuate over time. Aearch 61 (2006) 791–795
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heart transplantation, and personality factors have been
associated with posttransplant compliance, morbidity, and
mortality [8–10]. Emphasis, however, has primarily been on
personality disorders or on single, normal, personality traits,
rather than the interaction of traits. In addition, few studies
have investigated the impact of personality on HRQoL.
The distressed (Type D) personality is an emerging risk
factor for adverse health outcomes, impaired HRQoL,
fatigue, and several forms of distress, including anxiety,
depression, and posttraumatic stress, in patients with CVD
[6,11–16]. Type D is based on two normal, broad, and stable
personality traits (i.e. negative affectivity and social
inhibition), and is defined as the tendency to experience
increased negative distress paired with the nonexpression of
these emotions in social interactions [17]. The impact of
Type D personality has not yet been investigated in the
context of heart transplantation, although a derivation from
the Millon Health Behavioral Inventory (i.e. the bprototypic
high-distress patientQ) that resembles Type D has previously
been associated with increased risk of mortality in heart
transplant recipients [8].
The objective of the current study was to investigate
whether Type D personality is an independent determinant
of impaired HRQoL in this distinct patient group.Table 1
Patient characteristics stratified by Type D personality
Type D
(n =34)
Non-Type D
(n =152) P
Males (%) 79 73 .58
Age (years), mean (S.D.) 48 (12) 50 (10) .32
Time since transplant (years),
mean (S.D.)
8 (4) 7 (5) .41
No partner (%) 38 15 b.014
Low education (%) 47 22 b.014
Not working (%) 71 68 .91
2 or more rejection
episodes in the first
year posttransplantation (%)
35 45 .38
Need for renal replacement
therapy (%)
18 8 .11
Presence of malignancy (%) 18 20 .96
Diabetes posttransplantation (%) 16 22 .57
Cyclosporine-based
immunosuppressant therapya (%)
71 58 .24
a Versus tacrolimus-based immunosuppressant therapy.
4 Pb.01.Methods
Population and procedure
In February 2003, all surviving heart transplant recipients
z21 years of age (n=211) who had been transplanted in the
Erasmus Medical Centre Rotterdam between 1985 and early
2003 were approached in writing and asked to complete a
set of psychological questionnaires. A reminder was sent out
in April 2003 to nonresponders. All patients provided
written informed consent.
Measures
Demographic and clinical characteristics
Demographic factors (sex, age, marital status, education,
and working status) were obtained through purpose-
designed questions in the questionnaire. Clinical factors
(time since transplantation, number of rejection episodes in
the first year posttransplantation, the need for renal replace-
ment therapy, the presence of malignancy, diabetes post-
transplantation, and immunosuppressant medication) were
obtained from the medical records.
Type D personality
Type D personality was assessed with the Type D Scale
(DS14), a 14-item scale with 7 items measuring Negative
Affectivity (NA) (e.g., bI often feel unhappyQ) and 7 itemsmeasuring Social Inhibition (SI) (e.g., bI am a closed kind of
personQ) [17]. Items are answered on a 5-point Likert scale
ranging from 0 (false) to 4 (true). A standardised cutoff
z10 on both subscales indicates Type D caseness [17]. The
DS14 is a valid and reliable scale with Cronbach’s a of
.88 and .86 for the NA and SI subscales, respectively [17].
The test–retest correlations over a 3-month period were
.82 and .72 for the SI and NA scales, respectively [17]. It is
important to note that Type D reflects a normal personality
type rather than psychopathology, and that it is not merely a
measure of negative affect, such as depression, as it also
takes into account how patients deal with this affect [6,17].
Health-related quality of life
Perceived HRQoL was measured with the Short-Form
Health Survey 36 (SF-36), a standardised instrument
developed to measure functioning and well-being in primary
care populations and in patients with chronic diseases [18].
The SF-36 comprises 36 items, divided into eight subscales:
Physical Functioning, Role Physical Functioning, Social
Functioning, Role Emotional Functioning, Mental Health,
Vitality, Bodily Pain, and General Health. Scores on the
subscales are linearly converted to a score between 0 and
100, with a higher score representing a better functioning,
although for Bodily Pain a high score indicates less pain.
The Dutch version of the SF-36 has been validated in the
Dutch population and has a good internal consistency with a
mean Cronbach’s a of .84 across all scales [19]. Using an
algorithm, the eight subscales can be summarised into two
component summary scores, the Physical Component
summary score (PCS) and the Mental Component summary
score (MCS) [20].
Fig. 1. SF-36 component and subscale scores stratified by Type D personality. PCS=Physical Component summary; MCS=Mental Component summary;
PF=Physical Functioning; RPF=Role Physical Functioning; SF=Social Functioning; REF=Role Emotional Functioning; MH=Mental Health; VI=Vitality;
BP=Bodily Pain; GH=General Health.
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Discrete variables were compared with the chi-square test
(Fischer’s exact test when appropriate) and are presented as
percentages. Continuous variables were compared with the
Student’s t test and are presented as means with their
corresponding standard deviations (S.D.). Differences
between Type D and non-Type D personality on HRQoL
were analysed with MANOVA in order to adjust for
multiple comparisons. Multivariable logistic regression
analyses were used to examine whether Type D was an
independent determinant of impaired HRQoL. Prior to
analyses, the subscales of the SF-36 were recoded into
dichotomous variables, with the lowest tertile of each
subscale indicating poor QoL. Dichotomisation has also
been advocated by others in order to enhance clinical
interpretability [3,21]. In multivariable analyses, we
adjusted for all baseline characteristics listed in Table 1.
Odds ratios (ORs) with 95% confidence intervals (CIs) are
reported. All tests were two-tailed. A P value b.05 was
considered statistically significant. All statistical analyses
were performed using SPPS version 12.0.1.
Type D personality as a determinant of impaired HRQoL (adjusted
analyses)a
OR [95% CI] P
SF-36 component scores
PCS 3.62 [1.25–10.45] .024
MCS 6.13 [2.23–16.83] b.01
SF-36 subscales
Physical Functioning 3.96 [1.47–10.70] b.0144
Role Physical Functioning 3.52 [1.22–10.15] .024
Social Functioning 3.58 [1.38–9.27] b.0144
Role Emotional Functioning 5.17 [1.90–14.07] b.0144
Mental Health 5.95 [2.14–16.52] b.0144
Vitality 3.50 [1.24–9.93] .024
Bodily Pain 1.30 [0.50–3.38] .59
General Health 1.71 [0.64–4.56] .29
a Adjusted for sex, age, time since transplantation, marital status,
education, working status, two or more rejection episodes in the first year
posttransplantation, need for renal replacement therapy, presence of
malignancy, diabetes posttransplantation, and immunosuppressant therapy.
4 Pb.05.
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Patients characteristics
Of the 211 patients, 188 (89% response rate) completed
the questionnaires. Responders and nonresponders did not
differ on sex, age, and mean time since transplantation.
Given that 2 patients had incomplete data for the Type D
scale, analyses were based on 186 patients. The mean
time (S.D.) since transplantation for the 186 patients was 7
(5) years.
Of the 186 patients, 18% met the caseness criteria for
Type D personality. Patient characteristics at the time of the
survey stratified by Type D personality are presented in
Table 1. Type D patients were more likely to be single (38%
vs. 15%; P b.01) and to have low education (47% vs. 22%;
Pb.01) compared with non-Type D patients. No otherstatistically significant differences were found between the
two personality types on characteristics at the time of
completion of the questionnaires.
Impact of Type D personality on HRQoL
Type D patients had significantly worse mean scores
on the PCS (37 vs. 41; P=.04) and the MCS (45 vs. 55;
Pb.001) component scale scores of the SF-36 compared
with non-Type D patients (Fig. 1). In addition, except for
Bodily Pain, Type D patients had a significantly lower score
on all SF-36 subscales compared with non-Type D patients.
When adjusting for demographic and clinical variables,
Type D personality remained an independent determinant of
impaired PCS (OR, 3.62; 95% CI, 1.25–10.45) and MCS
(OR, 6.13; 95% CI, 2.23–16.83) (Table 2). Furthermore,
Type D personality was an independent determinant of
impaired HRQoL on all subscales of the SF-36, except for
Bodily Pain and General Health (Table 2). The risk
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independent predictors of impaired HRQoL were working
status (not working), being in dialysis, two or more rejection
episodes in the first year posttransplantation, female sex,
and time since diagnosis, depending on the HRQoL
subdomain in question (results not shown).Discussion
This is the first study to investigate the role of Type D
personality as a determinant of impaired HRQoL in heart
transplant recipients. We found that patients with a Type D
personality reported significantly poorer HRQoL compared
with non-Type D patients. When adjusting for the influence
of demographic and clinical characteristics, Type D
remained a strong independent determinant of impaired
HRQoL, with the risk ranging from more than three- to
sixfold.
Type D personality was an independent determinant of
impaired HRQoL, with the risk not only being statistically
significant but also clinically relevant given the more than
three- to sixfold increased risk. These findings concur with
those of earlier studies on Type D personality and impaired
HRQoL in patients with coronary artery disease [11],
chronic heart failure [15], and peripheral arterial disease
[16], showing that subgroups of patients with this person-
ality disposition are at increased risk of experiencing poor
HRQoL. However, in contrast to previous studies on Type
D, only 18% of the patients in the current study had a Type
D personality. This is well below the 24% to 30%
prevalence rates reported in other studies [11–16]. How-
ever, given that Type D has been associated with a four- to
eightfold increased risk of mortality [6,11], it is possible
that Type D patients rather than non-Type D patients died
prior to transplantation. Alternatively, due to a high score
on social inhibition Type D patients may present them-
selves differently to cardiologists than non-Type D patients
and voice less of a bfighting spirit,Q resulting in less of a
chance of being listed for transplantation.
The results of the current study should be interpreted
with some caution. First, the study was cross-sectional, and
patients were not approached at the time of transplantation
but at an average of 7 years after transplantation. There-
fore, we cannot rule out the possibility that heart trans-
plantation paired with the challenges these patients are
faced with, including the tight medical regimen, have
influenced scores on the Negative Affectivity and Social
Inhibition subscales of the Type D Scale and hence the
prevalence of patients with a Type D personality. However,
given the higher prevalence of Type D personality in
patients with established CVD, as mentioned previously,
and the stability of this personality taxonomy over time, it
is more likely that Type D personality is already present
prior to transplantation [17]. Second, heart transplant
recipients who died before the study were not included.These patients might have had a poorer HRQoL. However,
this is more likely to have led to an underestimation of the
effect of Type D on HRQoL rather than an overestimation.
Third, although the response rate was high (89%), bias
could have been introduced from nonresponders. In
addition, it is possible that there may be more Type D
patients among the nonresponders, although the Social
Inhibition component of Type D patients is less likely to
have an influence in a bsafeQ setting, such as completing
a questionnaire at home, compared with, e.g., in a face-
to-face interview. However, at least nonresponders did not
differ on sex, age, and mean time since heart trans-
plantation. Fourth, we used a generic rather than a disease-
specific instrument to assess HRQoL, with disease-specific
measures being more sensitive in terms of tapping symp-
toms pertinent to patients.
Strengths of the current study were the relatively large
sample size and response rate of 89%. In addition, the
results concur with previous results on Type D personality
and HRQoL in patients with coronary artery disease [11],
chronic heart failure [15], and peripheral arterial disease
[16]. Moreover, they extend our knowledge by showing that
Type D personality is of value in heart transplantation
research and may be used in clinical practice as a screening
tool in order to identify subgroups of heart transplant
patients at risk of impaired HRQoL.
In this context, however, it is important to emphasise that
having a Type D personality should not be used as a
contraindication for transplantation; rather, the purpose of
screening would be to identify those patients who require
additional support and intervention (e.g., of a psychosocial
nature). This may enhance secondary prevention in these
high-risk patients and allow Type D patients to benefit from
their new heart in terms of HRQoL and prognosis on par
with non-Type D patients. A recent study on the efficacy of
a multifaceted Internet-based intervention programme
designed to enhance the well-being and medical compliance
of heart transplant recipients showed a reduction in
symptoms of anxiety and depression and an increase in
HRQoL social functioning [22]. Type D patients may
benefit from a similar intervention, in particular given that
they may feel less threatened in sharing their emotions
(hence, lowering the Social Inhibition component) in this
more impersonal and anonymous setting.
Further research is necessary to understand the impact of
Type D personality on the HRQoL of heart transplant
recipients. Prospective studies are warranted to investigate
the role of Type D personality as a predictor of HRQoL over
time and to investigate the prevalence of Type D patients in
heart transplant populations at different time points, e.g.,
when entering the waiting list, around the moment of
transplantation, and at regular time points following trans-
plantation. Knowledge of the determinants of poor HRQoL
are not only important in order to optimise patient-centered
care [2], but poor HRQoL has also been found to predict
mortality in patients with CVD [3–5].
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more than a three- to fivefold increased risk of impaired
HRQoL in heart transplant recipients, adjusting for demo-
graphic and clinical characteristics. This shows that the
Type D personality construct has value in heart trans-
plantation recipients, and that the Type D Scale is a useful
screening tool in this distinct patient group to identify
subgroups at risk for impaired HRQoL. Prospective studies
are now warranted that investigate the impact of Type D
personality on HRQoL and clinical prognosis over time.References
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